Revefenacin, a Long‐Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo‐ and Positive‐Controlled Thorough QT Study

相似書籍

• Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function
  由: Borin, Marie T, et al.
  出版: (2019)
• Randomized, Double-Blind, Placebo- and Positive-Controlled Crossover Study of the Effects of Omadacycline on QT/QTc Intervals in Healthy Subjects
  由: Darpo, Borje, et al.
  出版: (2019)
• Comparing QT interval variability of semiautomated and high‐precision ECG methodologies in seven thorough QT studies—implications for the power of studies intended for definitive evaluation of a drug's QT effect
  由: Meiser, Karin, et al.
  出版: (2016)
• No QTc Prolongation With Zanubrutinib: Results of Concentration‐QTc Analysis From a Thorough QT Study in Healthy Subjects
  由: Mu, Song, et al.
  出版: (2020)
• Thorough QT/QTc Evaluation of the Cardiac Safety of Secnidazole at Therapeutic and Supratherapeutic Doses in Healthy Individuals
  由: Darpo, Borje, et al.
  出版: (2017)